Livzon Pharma plans industry fund, unit in alliance with Epirus Switzerland
Friday, September 25, 2015
Livzon Pharmaceutical Group Inc says unit Livzon Mabpharm signs collaboration agreement with Switzerland's Epirus Switzerland.
* Says plans to set up industry fund worth 500 million yuan ($78.35 million) with partner.
reuters.com
